Need to find a specific expert or member of a research group or division? Just search by role, division, name or browse our researchers A-Z.

Our leadership teamProfessor Kristian Helin Chief Executive and President The Chief Executive is responsible to the Board of Trustees for the overall direction of the ICR’s management, research and ...

Improving access to clinical trials Clinical trials are the single best way to turn advances in science into patient benefits. The ICR has a vision that a suitable trial should be made available for ...

Our projects Before the use of any regulated animal species in research, the research proposal and justification needs to be submitted as a project licence, which is reviewed by our Animal Welfare and ...

The Institute of Cancer Research Where we make the discoveries that defeat cancer We are a world-leading cancer research institute, a charity, and a member institution of the University of London.

The ICR and The Royal Marsden are internationally renowned for our work together to conduct early- and late-phase clinical trials. Our joint Drug Development Unit, which sees around 300 patients per ...

Scientists have developed a tool that can predict how bowel cancer adapts to treatment – helping researchers to design new personalised drugs that will keep patients living well for longer. A team ...

Thousands of patients with a common type of blood cancer could benefit from a new drug combination, while others could see their disease kept at bay for longer. Research published in the journal Blood ...

An immunotherapy helps patients live years longer without their cancer getting worse or coming back, a major phase III trial has found. Pembrolizumab kept cancer at bay for some patients for an ...

ASCO 2025: AI test determines best prostate cancer treatment – which could save NHS moneyA new AI test can pick out which men with high-risk prostate cancer that has not spread will require ...

Elen Hughes was first diagnosed with primary invasive lobular breast cancer in 2008 at the age of 37. Eight years later, her cancer returned and spread, and she has been on a rollercoaster journey ...